Edward Murray

Phase I clinical investigation of 1,4-dihydroxy-5,8-bis (( (2-[(2-hydroxyethyl)amino]ethyl) amino))-9,10-anthracenedione dihydrochloride (NSC 301739), a new anthracenedione.

Daniel D. Von Hoff, E. Parker Pollard, John G. Kuhn et al. · PubMed · 1980 · 124 citations

Pharmacy, Pharmacology, Cancer Drug Toxicity Management +8

The effects of the presence of others during a rowing exercise in a virtual reality environment

Edward Murray, David L. Neumann, Robyn L. Moffitt et al. · Psychology of sport and exercise · 2015 · 107 citations · Full text

Education, Behavioral Sciences, Psychology +12

Heparin-induced thrombocytopenia in patients receiving mechanical circulatory support

Sören Schenk, Aly El‐Banayosy, W. Prohaska et al. · Journal of Thoracic and Cardiovascular Surgery · 2006 · 71 citations · Full text

Medicine, Hematology, Surgery +11

Phase I clinical trial of mitoxantrone: A new anthracenedione anticancer drug

David S. Alberts, Katherine S. Griffith, Gary E. Goodman et al. · Cancer Chemotherapy and Pharmacology · 1980 · 59 citations

Medicine, Oncology, Pharmacology +9

The lipids of <i>Listeria monocytogenes</i>

K. K. Carroll, J H Cutts, Edward Murray · Canadian Journal of Biochemistry · 1968 · 55 citations

Life Sciences, Biochemistry, Microbiology +16